Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00188799
Status:
COMPLETED
Last Update Posted:
2015-07-16
First Post:
2005-09-12
Brief Title:
Xray Volume Imaging Cone Beam CT - Prostate Cancer
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Study Overview
Official Title:
A Clinical Study of X-ray Volume Imaging to Evaluate the Daily Set-up Accuracy of Conformal Prostate Radiotherapy
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Conformal dose escalated radiotherapy was adopted as the standard treatment technique at PMH for intermediate risk patients with localised disease in 1997 This technique provides a much smaller margin of error for treatment set-up and delivery than with conventional techniques One way to ensure the accuracy of treatment delivery is to image the prostate position daily prior to therapy to allow for appropriate set-up corrections To do so imaging markers are implanted into the prostate under guided ultrasound a standard procedure at PMH However there are disadvantages in using imaging markers which include added time to the treatment planning process and an invasive procedure with a potential for discomfort bleeding and infection This study will investigate and compare X-ray volume imaging to the gold standard imaging markers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Abbott-CARO Uro-OncologicAward | None | None | None |